No Data
No Data
Improve medical instruments (300030.SZ): the company has no products related to monkey pox.
On August 21, Improve Medical Instruments (300030.SZ) stated on the investor interaction platform that the company has no smallpox-related products.
Improve Medical Instruments: Summary of Half-Year Report in 2024.
Improve Medical Instruments: Half-year report for the year 2024.
Improve medical instruments (300030.SZ): net loss of 52.753 million yuan in the first half of the year, turning from profit to loss year-on-year.
Improving Medical Instruments (300030.SZ) released its 2024 interim report, showing a total operating income of 293 million yuan, a YoY decrease of 8.32%. The net loss attributable to shareholders of the listed company was 5.2753 million yuan, a YoY decrease of 150.41%. After deducting non-recurring gains and losses, the net loss attributable to shareholders of the listed company was 8.8048 million yuan, a YoY decrease of 206.03%. The basic eps was -0.02 yuan.
As of August 9th, 2024, the total number of shareholders for Improve Medical Instruments (300030.SZ) is approximately 0.027 million households.
Improving medical instruments (300030.SZ) announced on the investor interaction platform that as of August 9, 2024, the total number of shareholders was approximately 0.027 million.
At present, improve medical instruments' products are mainly used in medical institutions.
Improve Medical Instruments (300030.SZ) stated on their investor interaction platform on August 9th that their products are mainly used in medical institutions.
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Shares Bounce 31% But Its Business Still Trails The IndustryNo Data
